Treatment with Astragali Radix and Angelicae Radix Enhances Erythropoietin Gene Expression in the Cyclophosphamide-Induced Anemic Rat
Authors:
- 1 June 2009
- journal article
- research article
- Published by SAGE Publications in Journal of Medicinal Food
- Vol. 12 (3) , 637-642
Abstract
Anemia is a common cause of morbidity and disease and reduces the quality of life. This study examined the effect of a combination treatment (AAC) using Astragali radix (AMW) and Angelicae radix (AGW) in cyclophosphamide (CYP)-induced anemic rats on erythropoietin (EPO) expression and hematological parameters. Male 4-week-old Sprague-Dawley rats were divided into five groups with or without CYP-induced anemia and individual or the combined herbal treatments according to the experimental protocol. After treatment, reverse transcription-polymerase chain reaction was used to evaluate the effects of AAC on erythropoietin expression, and blood and serological parameters were measured. The EPO mRNA levels were lower in the CYP-treated group, compared to the normal group, and higher in the AAC-treated group. In the CYP-treated group, the serum iron concentration, total iron-binding capacity, and vitamin B12 level were lower, but these were normal or almost normal in the AAC-treated group. The CYP-treated group gained less weight than the normal group, but weight gain was partially normalized in the AAC group. The feed efficiency ratio was lowest in the CYP group, but the differences were not significant. The numbers of red blood cells, white blood cells, and platelets, the hematocrit, and the hemoglobin level were measured. The results revealed a reduced number of blood cells in the CYP-treated group, whereas the AAC-, AMW-, and AGW-treated groups showed significantly enhanced blood cell numbers compared to the CYP-treated control group and the AAC-treated group. AAC enhanced EPO mRNA expression in the CYP-induced anemic rat and improved the hematological parameters and vitamin B12 status.Keywords
This publication has 24 references indexed in Scilit:
- Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxellong-term follow-upInternational Journal of Gynecological Cancer, 2008
- Anaemia and congestive heart failure early post-renal transplantationNephrology Dialysis Transplantation, 2007
- Anemia as a risk factor for chronic kidney diseaseKidney International, 2007
- Pharmacodynamic model for chemotherapy-induced anemia in ratsCancer Chemotherapy and Pharmacology, 2007
- Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study GroupSupportive Care in Cancer, 2007
- Thirty years of cyclophosphamide: assessing the evidenceLupus, 2007
- Anemia in patients with diabetes mellitusMedicinski Pregled, 2007
- Control of cancer-related anemia with erythropoietic agents:a review of evidence for improved quality of life and clinical outcomesAnnals of Oncology, 2003
- Epoetin Alfa Treatment Results in Clinically Significant Improvements in Quality of Life in Anemic Cancer Patients When Referenced to the General PopulationJournal of Clinical Oncology, 2003
- Applications of darbepoietin-α, a novel erythropoiesis-stimulating protein, in oncologyCurrent Opinion in Hematology, 2002